IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.
Fujita Y, Nunez-Rubiano L, Dono A, Bellman A, Shah M, Rodriguez JC, Putluri V, Kamal AHM, Putluri N, Riascos RF, Zhu JJ, Esquenazi Y, Ballester LY.
Fujita Y, et al. Among authors: kamal ahm.
J Neurooncol. 2022 Sep;159(2):261-270. doi: 10.1007/s11060-022-04060-1. Epub 2022 Jul 11.
J Neurooncol. 2022.
PMID: 35816267
Free PMC article.